Spa Essetifin - Net Worth and Insider Trading

Spa Essetifin Net Worth

The estimated net worth of Spa Essetifin is at least $17 Million dollars as of 2024-11-08. Spa Essetifin is the 10% Owner of Fennec Pharmaceuticals Inc and owns about 3,993,694 shares of Fennec Pharmaceuticals Inc (FENC) stock worth over $17 Million. Spa Essetifin is the of Soligenix Inc and owns about 1,223 shares of Soligenix Inc (SNGX) stock worth over $4,244. Spa Essetifin is also the 10% Owner of Regenerx Biopharmaceuticals Inc and owns about 318,554 shares of Regenerx Biopharmaceuticals Inc (RGRX) stock worth over $446. Besides these, Spa Essetifin also holds SciClone Pharmaceuticals Inc (SCLN) . Details can be seen in Spa Essetifin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Spa Essetifin has not made any transactions after 2020-04-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Spa Essetifin

To

Spa Essetifin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Spa Essetifin owns 4 companies in total, including Regenerx Biopharmaceuticals Inc (RGRX) , Fennec Pharmaceuticals Inc (FENC) , and Soligenix Inc (SNGX) among others .

Click here to see the complete history of Spa Essetifin’s form 4 insider trades.

Insider Ownership Summary of Spa Essetifin

Ticker Comapny Transaction Date Type of Owner
RGRX Regenerx Biopharmaceuticals Inc 2018-03-13 10 percent owner
FENC Fennec Pharmaceuticals Inc 2020-04-30 10 percent owner
SNGX Soligenix Inc 2017-11-29 10 percent owner
LIMIT LIMIT 2012-04-30 10 percent owner

Spa Essetifin Latest Holdings Summary

Spa Essetifin currently owns a total of 4 stocks. Among these stocks, Spa Essetifin owns 3,993,694 shares of Fennec Pharmaceuticals Inc (FENC) as of April 30, 2020, with a value of $17 Million and a weighting of 99.97%. Spa Essetifin owns 1,223 shares of Soligenix Inc (SNGX) as of November 29, 2017, with a value of $4,244 and a weighting of 0.02%. Spa Essetifin also owns 318,554 shares of Regenerx Biopharmaceuticals Inc (RGRX) as of March 13, 2018, with a value of $446 and a weighting of 0%. The other 1 stocks SciClone Pharmaceuticals Inc (SCLN) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Spa Essetifin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FENC Fennec Pharmaceuticals Inc 2020-04-30 3,993,694 4.36 17,412,506
SNGX Soligenix Inc 2017-11-29 1,223 3.47 4,244
RGRX Regenerx Biopharmaceuticals Inc 2018-03-13 318,554 0.00 446
SCLN SciClone Pharmaceuticals Inc 2012-04-30 0 11.15 0

Holding Weightings of Spa Essetifin


Spa Essetifin Form 4 Trading Tracker

According to the SEC Form 4 filings, Spa Essetifin has made a total of 1 transactions in Fennec Pharmaceuticals Inc (FENC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Fennec Pharmaceuticals Inc is the acquisition of 768,000 shares on April 30, 2020, which cost Spa Essetifin around $5 Million.

According to the SEC Form 4 filings, Spa Essetifin has made a total of 0 transactions in Soligenix Inc (SNGX) over the past 5 years. The most-recent trade in Soligenix Inc is the sale of 1,223 shares on November 29, 2017, which brought Spa Essetifin around $622,241.

According to the SEC Form 4 filings, Spa Essetifin has made a total of 0 transactions in Regenerx Biopharmaceuticals Inc (RGRX) over the past 5 years. The most-recent trade in Regenerx Biopharmaceuticals Inc is the acquisition of 179,337 shares on March 13, 2018, which cost Spa Essetifin around $4 Million.

More details on Spa Essetifin's insider transactions can be found in the Insider Trading History of Spa Essetifin table.

Insider Trading History of Spa Essetifin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Spa Essetifin Trading Performance

GuruFocus tracks the stock performance after each of Spa Essetifin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Spa Essetifin is 24.12%. GuruFocus also compares Spa Essetifin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Spa Essetifin within 3 months outperforms 13 times out of 25 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Spa Essetifin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Spa Essetifin

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
4 out of 25 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 13.63 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 13.06 LIMIT LIMIT LIMIT LIMIT LIMIT

Spa Essetifin Ownership Network

Ownership Network List of Spa Essetifin

No Data

Ownership Network Relation of Spa Essetifin

Insider Network Chart

Spa Essetifin Owned Company Details

What does Regenerx Biopharmaceuticals Inc do?

Who are the key executives at Regenerx Biopharmaceuticals Inc?

Spa Essetifin is the 10 percent owner of Regenerx Biopharmaceuticals Inc. Other key executives at Regenerx Biopharmaceuticals Inc include other: Member of 10% owner group Aptafin S P A , 10 percent owner Francesca Cavazza , and 10 percent owner Silvia Cavazza .

Regenerx Biopharmaceuticals Inc (RGRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Regenerx Biopharmaceuticals Inc (RGRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Regenerx Biopharmaceuticals Inc (RGRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Regenerx Biopharmaceuticals Inc (RGRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Regenerx Biopharmaceuticals Inc Insider Transactions

No Available Data

Spa Essetifin Mailing Address

Above is the net worth, insider trading, and ownership report for Spa Essetifin. You might contact Spa Essetifin via mailing address: Via Sudafrica 20, Rome L6 00144.